AI assistant
MACROGENICS INC — Director's Dealing 2025
Aug 21, 2025
34129_dirs_2025-08-21_457fe0ff-4777-4b06-91a6-025c310aca7a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-08-19
Reporting Person: HEIDEN WILLIAM K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-19 | Common Stock | P | 50500 | $1.52 | Acquired | 61500 | Direct |
| 2025-08-20 | Common Stock | P | 49500 | $1.49 | Acquired | 111000 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $1.48 to $1.59. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: This transaction was executed in multiple trades at prices ranging from $1.46 to $1.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.